Western Standard discloses 6.3% stake in Merrimack Pharmaceuticals - InvestingChannel

Western Standard discloses 6.3% stake in Merrimack Pharmaceuticals

Eric Andersen’s Western Standard disclosed a 6.3% stake in Merrimack Pharmaceuticals, which represents 842,913 shares. The filing with the SEC allows for activism. Western Standard purchased the shares based on its belief that the shares, when purchased, “were undervalued and represented an attractive investment opportunity,” according to the filing. Western Standard added that the purchases were made “in the ordinary course of business and were not made for the purpose of acquiring control” of Merrimack.